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Neurobiology of Disease
Conserved Chromosome 2q31 Conformations Are
Associated with Transcriptional Regulation of GAD1 GABA
Synthesis Enzyme and Altered in Prefrontal Cortex of
Subjects with Schizophrenia
Rahul Bharadwaj,1,2 Yan Jiang,3Wenjie Mao,1,2Mira Jakovcevski,4 Aslihan Dincer,3Winfried Krueger,5
Krassimira Garbett,6 CatheryneWhittle,2 Jogender Singh Tushir,2 Jia Liu,3 Adolfo Sequeira,7Marquis P. Vawter,7
Paul D. Gardner,2 Patrizia Casaccia,3 Theodore Rasmussen,5William E. Bunney Jr,7 Karoly Mirnics,6 Kensuke Futai,2
and Schahram Akbarian2,3
1Graduate School of Biomedical Sciences and 2Brudnick Neuropsychiatric Research Institute, University of Massachusetts Medical School, Worcester,
Massachusetts 01655, 3Departments of Psychiatry and Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York,
New York 10029, 4Max Planck Institute of Psychiatry, 80804 Munich, Germany, 5Center for Regenerative Biology and Department of Pharmaceutical
Sciences, University of Connecticut, Storrs, Connecticut 06269, 6Department of Psychiatry, Vanderbilt University, Nashville, Tennessee 37232, and
7Department of Psychiatry and Human Behavior, University of California, Irvine, California 92697
Little is known about chromosomal loopings involving proximal promoter and distal enhancer elements regulating GABAergic gene
expression, including changes in schizophrenia and other psychiatric conditions linked to altered inhibition. Here, we map in human
chromosome 2q31 the 3D configuration of 200 kb of linear sequence encompassing theGAD1GABA synthesis enzyme gene locus, andwe
describe a loop formation involving theGAD1 transcription start site and intergenic noncoding DNA elements facilitating reporter gene
expression. The GAD1-TSS-50kbLoop was enriched with nucleosomes epigenetically decorated with the transcriptional mark, histone H3
trimethylated at lysine 4, and was weak or absent in skin fibroblasts and pluripotent stem cells compared with neuronal cultures
differentiated from them. In the prefrontal cortex of subjects with schizophrenia, GAD1-TSS-50kbLoop was decreased compared with
controls, in conjunction with downregulated GAD1 expression. We generated transgenic mice expressing Gad2 promoter-driven green
fluorescent protein-conjugated histone H2B and confirmed that Gad1-TSS -55kbLoop, the murine homolog to GAD1-TSS-50kbLoop, is a
chromosomal conformation specific for GABAergic neurons. In primary neuronal culture, Gad1-TSS -55kbLoop and Gad1 expression
becameupregulatedwhenneuronal activitywas increased.We conclude that 3D genome architectures, including chromosomal loopings
for promoter-enhancer interactions involved in the regulation of GABAergic gene expression, are conserved between the rodent and
primate brain, and subject to developmental and activity-dependent regulation, and disordered in some cases with schizophrenia. More
broadly, the findings presented here draw a connection between noncodingDNA, spatial genome architecture, and neuronal plasticity in
development and disease.
Introduction
Psychosis and defective cognition in some cases with schizophre-
nia and bipolar disorder are thought to be rooted in molecular
and cellular defects of the cortical inhibitory (GABAergic) cir-
cuitry, resulting in altered synchronization of electrical activity
across widespread brain regions (Fatemi et al., 2005; Zhang et al.,
2008; Lewis et al., 2012; Uhlhaas and Singer, 2012). The empirical
framework for this hypothesis is based, among others, on a large
body of postmortem literature reporting downregulated RNA
and protein levels for the rate-limiting GABA synthesis enzyme,
67 kDa glutamic acid decarboxylase (GAD67), inmultiple subtypes
of cortical interneurons, including those commonly defined as fast-
spiking, parvalbumin (PV), and low-treshold spiking soma-
tostatin cells (Akbarian and Huang, 2006; Fung et al., 2010;
Konradi et al., 2011a; Schmidt andMirnics, 2012). There is evidence
that 30% or 40% of subjects with schizophrenia are affected by a
more robust deficit in cortical gene expression, affectingGAD67, the
transcription factorLHX6, andvariousneuropeptides selectively ex-
pressed by interneurons (Volk et al., 2012).
Of note, single nucleotide polymorphisms in the proximal
GAD1 promoter confer genetic risk for schizophrenia, impaired
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working memory performance, and accelerated loss of gray matter
(Addington et al., 2005; Straub et al., 2007), possibly in conjunc-
tion with altered expression of the cation chloride cotransporters
NKCC1/KCC2, two key regulators of postsynaptic GABAA
receptor-mediated currents (Hyde et al., 2011). These findings, in
conjunction with altered chromatin structures at the proximal
GAD1 promoter, including a shift from open toward repressive
chromatin-associated histone modifications and abnormal DNA
methylation signatures (Huang et al., 2007; Tang et al., 2011;
Grayson andGuidotti, 2012), firmly point to transcriptional dys-
regulation as a key factor for GABAergic dysfunction in schizo-
phrenia. However, the regulation of gene expression in a
vertebrate cell goes far beyond the genetic and epigenetic archi-
tectures of proximal promoters and transcription start sites
(TSSs). Instead, chromosomes and gene expression units inside
the cell nucleus are organized as highly complex dynamic 3D
structures that includes chromosomal loopings via direct physi-
cal interactions of enhancer and promoter elements with TSSs
(Deng and Blobel, 2010; Ribeiro de Almeida et al., 2011; Singh et
al., 2012). To date, however, the regulation of supranucleosomal
and higher-order chromatin structures, beyond the level of DNA
methylation and post-translational modifications of the core hi-
stones (which together with 146 bp of DNA wrapped around
them comprise the nucleosome as the fundamental unit of chro-
matin), essentially remains unexplored in normal or diseased
human brain.
Here, we explore 3D chromosomal architectures encompass-
ing 200 kb of chromosome 2q31 in prefrontal cortex (PFC) of
subjects with schizophrenia and controls, cultured human and
mouse (chromosome 2qC2) neurons and their pluripotent pre-
cursors, and in transgenic animals tagged for GABAergic chro-
matin. We identify, for the first time, conserved regulatory DNA
elements in rodent and primate genomes that are engaged in a
loop formation with the GAD1/Gad1 TSS and present multiple
lines of evidence that dynamic regulation of 3D genome struc-
tures plays a critical role for orderly development and function of
GABAergic systems in the human brain.
Materials andMethods
iPS reprogramming of human dermal fibroblasts. Fibroblasts from a 43-
year-old (hDF6, ATCC)healthy femalewere reprogrammedusing a pub-
lished protocol (Maherali et al., 2008) withminormodifications. Briefly,
passage 6 cells were reprogrammed by infection of 3  105 fibroblasts
with a mixture of lentivirus particles (Openbiosystems) containing ge-
nomes encoding OCT4, SOX2, KLF4, and human c-MYC at a multiplic-
ity of infection of 5:5:5:2.5 (hDF6). Infected cells were grown for 4 d in
fibroblast growth medium (DMEM/10% FCS), but 3 d after infection,
each 100,000 fibroblasts were passaged into 10 cm tissue culture dishes
and grown on feeder cells until candidate colonies were harvested. On
day 4, the fibroblast growth medium was replaced with human ES cell
medium (80% DMEM/F12) (Invitrogen), 20% knock-out serum re-
placement (Invitrogen), 1nonessential amino acids (Invitrogen), 1mM
glutamine (Invitrogen), 100 M -mercaptoethanol (Invitrogen), and 5
ng/ml fibroblast growth factor 2 (FGF2) (R&D Systems). The culture
medium was replaced daily until all candidate colonies were harvested.
This approach yielded colonies with embryonic stem cell morphology at
a frequency of 8  105 (data not shown). From day 30 onwards, can-
didate iPS cell colonies were harvested using glass knives (Vitrolife),
transferred into culture wells of 6-well plate containing fresh mouse
embryonic fibroblast feeder cells and expanded to colonies with a diam-
eter of 1–2 mm. Candidate iPS cells with a modal chromosome number
of 46 were then maintained further feeder free conditions onMatrigel in
the presence of mTESR1.
Assessment of pluripotency. Pluripotency was determined initially by
immunofluorescent detection of endogenous expression of Nanog and
Tra1-60. Surface pluripotency marker expression for Tra1–60 and
SSEA4 was confirmed using fluorescence activated cell sorting. We next
confirmed by qRT-PCR the expression of OCT4 and REX1 mRNAs. We
assessed pluripotency further through targeted differentiation into all
three germlayers and detection of Sox17 (endoderm), Otx2 (ectoderm),
or Brachyury (mesoderm) protein expression by immunofluorescence.
Finally, we also produced embryoid bodies from our iPSCs and assessed
expression of Nestin and Neuropilin 2 (neuroectoderm), SOX17 and
Alpha-Feto Protein (endoderm), and KDR, Matrilin 1, Myf5, and
Brachyury (mesoderm). LineW(K)6 iPSwas grown feeder free onMatri-
gel (BD Biosciences; 356231) and collected with dispase, and embroid
bodies were formed using Aggrewell 400 plates (Stem Cell Technologies;
27845). After growing the iPS cells for 1–2 d, embroid bodies were col-
lected and moved into nonadherent flasks, with HES media changed
daily for 4 d and on the fifth day changed to neural induction (NI)media
containing FGF2. On day 6, the aggregates were plated on coated tissue
culture plates (poly-l-ornithine/laminin) in NI media FGF2 and pro-
cessed similar as described above for H9ESC. For chromosome confor-
mation capture (3C) assays, 8–15  106 stem cells (or differentiated
neurons, see below) were used as input.
Neuronal differentiation assays (human).Depending on the strength of
the chromosomal interactions and sensitivity of the PCR assays, conven-
tional chromosome conformation capture (3C) often requires 106 to 107
nuclei as input (Miele and Dekker, 2009). Therefore, we modified exist-
ing protocols to induce neural differentiation in a larger number of cells.
Briefly, the W6 iPS were grown feeder free on Matrigel (BD Biosciences;
356231) and collected with dispase, and embroid bodies were formed
using Aggrewell 400 plates (Stem Cell Technologies; 27845). After grow-
ing the iPS cells for 1–2 d, embroid bodies were collected andmoved into
nonadherent flasks, with HES media changed daily for 4 d and on the
fifth day changed to NImedia containing FGF2. On day 6, the aggregates
were plated on coated tissue culture plates (poly-L-ornithine/laminin) in
NI media FGF2, changing the media every second day. By day 11–14,
neural rosettes were forming. At approximately day 14, these primary
neural rosettes were mechanically removed from the plate and grown in
suspension for 2 d in a nonadherent flask, then replated in NI  FGF2.
After 2 d, the media is changed to a modified (by the addition of N2
supplement) neural proliferation media (NP)  FGF2  leukemia in-
hibitory factor (LIF) (Dhara et al., 2008). The cells are grown for a further
6–10 d in changing the media every second day. At approximately day
24–28, the secondary neural rosettes were collected and grown for 2 d in
suspension and then replated on (poly-L-ornithine/laminin) in NP me-
dia FGF2 LIF with the addition of 200 M Sonic hedgehog for 24 h,
grown for another 7–12 d. Then, tertiary neural rosettes were collected in
1HBSS, incubated for 10–30min, and then titrated gently to break up
the rosettes, and the cells replated in NP media FGF2 LIF with the
addition of 200 M Sonic hedgehog for 24 h. After 1–2 d, the cells are
grown in neural differentiation media (Sara et al., 2005) for 6–12 d and
then harvested.
Human dermal fibroblasts. Fibroblasts (from two unrelated donors,
including hDF6) were grown in batches of four T175 flasks in DMEM,
15% Hyclone serum  0.5 ml glutamine and 1  nonessential amino
acids. After confluency (day 6), cells were harvested and processed for 3C
as above.
Postmortem brain tissue. For the clinical studies, specimens from the
rostral third of the dorsolateral prefrontal cortex of 10 subjects diagnosed
with schizophrenia (4 females/5males, age range 40–87 years; tissue pH,
6.1–7.2) and 7 controls (2 females, 6 males; age range 41–90 years; tissue
pH, 6.1–7.2) were included in this study. An independent set of 6 con-
trols (4 females, 2 males; age range 16–81 years), and RNA integrity
number from 4.1 to 9.0 was used for RNAseq experiments. Specimens
were fromabrain bank at theUniversity ofCalifornia at Irvine andDavis.
Procedures for tissue collection, neuropathologic examination (to rule
out degenerative and neurologic disease), diagnosing schizophrenia us-
ingDSM-IV-based diagnostic criteria were described previously (Akbar-
ian et al., 1995; Huang et al., 2007).
Generation of Gad2-H2BGFP transgenic mice. Transgenic mice were
generated by injection of circular modified bacterial artificial chromo-
some (BAC) into fertilized C57BL/6 mouse oocytes by the University of
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California Irvine Transgenic Mouse Facility (http://www.research.uci.
edu/tmf/), using BAC RP23 27D24, containing the mouse glutamate de-
carboxylase 2 (mGad2) locus (chromosome 2: 22,453,784–22,682,644,
NCBI Build 37.1) (http://bacpac.chori.org/), including the mGad2 gene
(chromosome 2: 22,478,000–22,550,009, strand). BAC modifications
were performed to insert H2BGFP-FRT-neo-FRT at the Gad2 start
codon, and then the selection marker (neomycin) cassette was removed
via FRT directed recombination, the BAC modifications further con-
firmed with restriction mapping and sequencing.
Primary hippocampal neuron culture (mouse). All animal experiments
were approved by the Animal Use and Care Committees of the partici-
pating institutions. Primary hippocampal cultures were prepared from
early postnatal (P0-P1) mouse as described previously (Brewer et al.,
1993) with some modifications (Futai et al., 2013). Briefly, hippocampi
were dissected and trypsinized, after which neurons were dissociated and
plated onto coverslips coated with poly-D-lysine (40g/ml) and laminin
(4g/ml) at a density of 500 cell/mm2. Neurons weremaintained in B27
containing medium for 14 d in vitro and treated with picrotoxin (100
M), tetrodotoxin (1M), or equal volume ofDMSO for 15 h. Total RNA
was extracted using RNAqueous Micro Kit (Ambion) and reverse tran-
scribed using High Capacity RNA-to-cDNA Kit (Applied Biosystems).
Real-time quantitative PCR was then performed on an ABI 7500 Fast
sequence detection system (Applied Biosystems) using TaqMan assay
(Applied Biosystems). Gene expression levels in drug-treated groups or
control groups (DMSO-treated) were analyzed in 3 independent cul-
tures in PCR duplicates. Glyceraldehyde-3-phosphate-dehydrogenase
(Gapdh) was used as reference gene, and fold change of Gad1 expression
level in drug-treated groups relative to control group was determined
using the 2CT method [CT values  (CTgad1  CTgapdh)treated 
(CTgad1 CTgapdh)control](Livak and Schmittgen, 2001).
Antipsychotic drug treatment. For antipsychotic drug studies, adult
male C57BL/6Jmice, 10–15 weeks of age, were treated acutely or for 21 d
with once daily intraperitoneal injections of saline or haloperidol (0.5
mg/kg) or clozapine (5 mg/kg) (Sigma). Tissue (PFC) was harvested 60
min after the last treatment.
Immunohistochemistry. Gad2-H2BGFP mice were anesthetized and
perfused transcardially with cold 4% PFA in 1 PBS. Brains were har-
vested andpostfixed in 4%PFAovernight and then cryoprotected in 30%
sucrose in 0.1 m PBS. Brains were sectioned 30 m thick on a freezing
microtome. Immunostaining was done with free-floating sections using
Tyramide-Plus signal amplification system. Briefly, sections were incu-
bated with primary antibodies against calretinin (1:1000, SWANT) or
parvalbumin (1:1000, SWANT), followed by biotin-tagged secondary
antibody incubation (1:200; Jackson ImmunoResearch Laboratories),
ABC (Vector Laboratories) treatment, and Tyramide-Plus signal ampli-
fication (1:50, PerkinElmer Life and Analytical Science). Sections were
mounted to slides using VECTASHIELDmountingmediumwith DAPI.
Chromosome conformation capture (3C).Cerebral cortex (300–500mg
of gray matter/specimen) was homogenized in 1  PBS-buffered, 1.5%
formaldehyde to cross-link higher-order chromatin (of note, based on
flow cytometry of purified nuclei from postmortem specimens, there are
at least 3–4  106 physically intact nuclei in a 300 mg piece of cortical
gray matter) (Jiang et al., 2008). After 15 min, cross-linking was stopped
by the addition of glycine to 0.125 M final concentration) and samples
spun in a tabletop centrifuge c at 4000 rpm for 10 min at 4°C; then the
pellet was resuspended in 2 ml of cellular lysis buffer (10 mM Tris-HCl,
pH 8.0/10 mM NaCl/0.2% Ige cal CA630) and incubated at room tem-
perature for 45 min. Next, samples were homogenized by constant pi-
petting and spun at 5000 rpm for 5min, the supernatant removed and the
pelleted nuclei stored at80°C.
Cell culture.Media was aspirated, followed by a quick wash with 37°C
1  PBS. Then 5 ml of 1  PBS/1.5% formaldehyde was added to the
cultures, the cells scrapped, and kept in suspension for 10 min. Then
cross-linking was stopped by the addition of glycine to 0.125 M and cells
harvested by centrifugation at 1200 rpm/5min. The pellet is treated with
1 cellular lysis buffer after adding one-tenth volume of protease inhib-
itor mixture (Sigma), resuspended, and left at room temperature for 15
min, followed by homogenization and nuclei pelleting (5000 rpm for 5
min) and twowashes with 1NewEngland Biolabs2 [NEB2] restriction
enzyme buffer).
Restriction digestion.Nuclei were resuspended in 250 l of 1NEB2,
divided into 5 50l aliquots, to each of which 312l of 1NEB2 and
38l of 1%SDSwere added, followed by gentlemixing and incubation at
65°C for 10 min to remove proteins that are not directly associated with
DNA and facilitate more efficient digestion. Then, 44l of Triton X-100
was added to each sample to quench the SDS by gentle pipetting, and
samples were digested with 400 units of HindIII (NEB) at 37°C overnight
with gentle shaking.
Ligation and reverse cross linking. To inactivate HindIII, 86 l of 10%
SDS (Bio-Rad) was added and samples were incubated at 65°C for 30
min. Then, each sample was added to 7.61 ml of ligation reaction mix-
ture. Each mixture consisted of 745 l of 10% Triton X-100, 745 l of
10 ligation buffer [1 M Tris HCl, pH 7.5, 1 M MgCl2, 1 M DTT dithio-
threitol (Bio-Rad)], 80l of 10 mg/ml bovine serum albumin (NEB), 80
l of 100 mM ATP (Sigma) and 5960 l of H2O. To each mixture, 50 l
of T4 DNA ligase (1 U/l; Invitrogen) was added and incubated at 16°C
for 4 h followed by reverse cross-linking at 65°C overnight with simulta-
neous Proteinase K digestion [50 l of 10 mg/ml Proteinase K (Sigma)
reconstituted with TE buffer pH8.0] to digest chromatin-associated pro-
teins. To improve ligated DNA recovery, another 50 l of Proteinase K
was added and incubated at 65°C for 2 h.
DNA purification and recovery. Ligated samples were phenol extracted
(pH 8.0, Fisher) followed by phenol-chloroform (1:1) (pH 8.0, Omni-
pur) followed by ethanol precipitation. DNA was dissolved in 1  TE
buffer (pH 8.0).
For 3C studies in Gad2-H2BGFP transgenic mice, 0.2–0.3  106
GFP nuclei and 48  106 GFP nuclei were separately sorted and
collected from cerebral cortex using fluorescence-activated nuclei sort-
ing as described previously (Jiang et al., 2008). Additional 3C studies
were conducted in whole cortex of adult C57BL/6J wild-type mice or on
the primary neuronal cultures described above.
3C quantification.Wemapped physical interactions of noncontiguous
DNA elements within a 200 kb region of chromosome chromosome 2
(171,573,000–171,797,000;HG19), encompassingGAD1 (Fig. 1) by PCR
across the ligation junctions of interacting fragments. Primers were de-
signed according to 3C guidelines (Miele and Dekker, 2009), with 30 bp
in length and positioned within 60 bp of the restriction enzyme cut site, a
melting temperature of 60°C, and with a GC% content of 45%. From a
total of 55 HindIII fragments, 11 fragments yielding primer sequences in
accordance with these primer selection criteria were probed by specific
primers positioned in the 5 to 3 direction on the sense strand amplify-
ing toward the end of the respective restriction fragment were used. The
anchor primer for all PCR represented the HindIII fragment containing
the TSS of GAD1. All primers were 30–32 nt in length, melting temper-
ature  60°C, and positioned  200 bp from a HindIII restriction site.
PCR products were resolved in agarose gels and the level of interaction
between any two fragments in the 3C libraries measured semiquantita-
tively. To this end, amplicons generated by PCR across a single ligation
junction run in triplicate on 2% agarose/1xTAE/130V/25 min and band
intensities measured by UVP Bioimaging system/Labworks version 4.5
software, after background subtractions from blank gel regions. We
used a BAC (clone ID-RP11–570C16, representing chromosome 2:
171552700–171745852; http://bacpac.chori.org) to control for primer
efficiency (Dekker, 2006; Miele and Dekker, 2009). To control for
ligation efficiencies across independent 3C experiments/samples, we
mapped physical interactions of noncontiguousDNAelementswithin 75
kb of chromosome 16 (62,275,000–62,350,000; HG19) in a previously
described “gene desert” region with the two nearest genes (CDH8 and
CDH11) located 200 kb upstream and 2.6Mb downstream (Ferraiuolo et
al., 2010).
Furthermore, we mapped physical interactions of noncontiguous
DNA elements within a 70 kb region of chromosome mouse chr2qC2
(chromosome 2: 70,340,000–70,410,069; mm9), to interrogate loop for-
mations of DNA sequences positioned up to 100 kb upstream of Gad1
TSS.
Promoter/enhancer assays. Luciferase reporter gene assays were per-
formed using the minimal promoter (TATA box) luciferase vector
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(pGL4.23 [luc2/minP] vector; Promega; E8411) in HEK-293 cell cul-
tures. Specifically, 115 bp (chromosome 2: 171622200–171622315) was
cloned into the multiple cloning site of the luciferase vector and sequence-
verified clones transfected intoHEK-293 cells with Lipofectamine-2000 (In-
vitrogen). Furthermore, control plasmids were generated with a 125 bp
sequence (chromosome 2: 171645000–171645125) from an upstream re-
gionrestriction fragment thatwasnot surroundedbyH3K4me1orH3K27ac
peaks in various Encyclopedia of DNA Elements Consortium (ENCODE)
cell lines and did not harbor AP-1 motifs. As an additional control, Renilla
luciferase vector (Prl-TK;Promega; E2241)was cotransfected into everywell
to correct for variations in transfection efficiency. Cells were harvested and
lysed 48 h after transfection using lysis buffer from the Promega luciferase
assay kit (catalog #E1910) and firefly luciferase units quantified (kit
luciferase substrate) using the Bio-Rad luminometer followed by mea-
surement of Renilla luciferase units by chemiluminescence (kit Stop&Glo re-
agent) according to the manufacturer’s protocol. Relative luciferase units were
calculated relative tominimal TATAboxdriven luciferase units.
3C-ChIP loop. Cross-linked nuclei were restriction digested as de-
scribed in the 3Cmethod usingHindIII (NEB) enzyme. Digested restric-
tion fragments were then washed with FSB (20mMTris-Cl, pH 7.5, 5mM
EDTA, 50 mM NaCl final concentration) followed by immunoprecipita-
tion (anti-H3K4me3 1 g/l; 1:1000 dilution; ab8898, Abcam) at 4°C
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Figure 1. Chromosome 2q31 conformation at the GAD1 locus. A, Genome map for 200 kb surrounding GAD1 TSS, including 50 kb GAD1 gene body and surrounding sequences as indicated.
Browser tracks showing H3K4me3 landscape at 2q31 in PFC neurons, and H3K27ac and H3K4me1 (composite ChIP-seq tracks from 3 ENCODE cell lines). Red and green boxes represent two HindIII
restriction fragments that harbor sharp H3K4me3 peaks in PFC neurons. B, x-y graphs present chromosome conformation capture (3C) profiles across the 200 kb portion of chromosome
2q31 for (top) skin fibroblasts, FIB (N 2 donors) and (bottom) prefrontal cortex, PFC (N 4 donors) as indicated. Each data point expresses the interaction frequency between a specific
restriction fragment with the TSS. Data are mean SD. 3C maps were anchored on TSS containing fragment (green). There is significant interaction (one-way ANOVA, **p 0.001 Bonferroni
corrected) between two CpG-rich, H3K4me3 decorated sequences in the PFC (A, red and green boxes; and referred to as GAD1-TSS-50kbLoop in the text). Representative gel images for PCR products
from 3C assays, showing a specific interaction between red- and green-marked HindIII fragment as indicated (green box represents primer 5-GGGCGGGAAAGGTGCATAAAACTGAGACTGA, hg19
chromosome2: 171675735–171675765; redbox, primer 5-GTCCTTCAAAACACGTTGCCTAGCAACAAA, hg19 chromosome2: 171626697–171626726).C, Robust expressionofGAD1RNA inPFCbut not
in FIB (N 3/tissue, mean SEM, *p 0.05, Wilcoxon signed-rank test), as determined by qRT-PCR after normalization to 18s rRNA. D, Top, Workflow and results of 3C-ChIP looP experiments.
Schematic illustration of 3D chromatin structures atGAD1 locus, including physical proximity between GAD1 TSS sequences (green) and putative enhancer (red) as described in A,B. Chromatin
is formaldehyde-crosslinked, followed by HindIII restriction digest, anti-H3K4me3 immunoprecipitation, and religation and 3C PCR to map noncontiguous DNA elements. There is robust
PCR-based amplification of noncontiguous DNA sequences from green- and red-marked sequences (GAD1-TSS-50kbLoop) but only weak or nondetectable PCR signal in controls (IgG pulldown with
ligase and H3K4me3 pulldown without ligase treatment).
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overnight in FSB with phenyl methyl sulfonyl fluoride (0.1 M final
concentration), dithiothreitol (3 M final concentration), and benzami-
dine (0.1M final concentration). Antibody–chromatin complexes were
then isolated using protein G agarose slurry followed by elution as de-
scribed previously (Huang et al., 2007). The immunoprecipitated chro-
matin fragments were then ligated with T4 DNA ligase (Invitrogen) as in
the 3C protocol step. Ligated fragments were then reverse cross-linked
and digested with Proteinase K (Invitrogen, catalog #25530–031) and
purified to generate the 3C-ChIP loop library using phenol/phenol-
chloroform extraction followed by ethanol precipitation as in 3C. Quan-
tification of interacting fragments from H3K4me3 ChIP-3C, and for
control, IgG-3C and H3K4me3 ChIP-3C (no ligase) libraries was done
exactly as for 3C quantification from conventional 3C assays described
above. The H3K4me3 ChIP-3C, IgG-3C, and H3K4me3 ChIP-3C (no
ligase) assays and libraries were processed in parallel using the same
protocol and solutions.
CBP-ChIP. Chromatin from cerebral cortex from one hemisphere of
adult C57BL/6J mice (N 3) was prepared by formalin crosslinking and
sonication as described previously (Jiang et al., 2010), for ChIP with an
antibody raised against the C terminus of the cAMP-response element
binding protein (CREB)-binding protein (CBP/CREBBP) (Abs c-583,
rabbit polyclonal, Santa Cruz Biotechnology). For PCR-based quantifi-
cations of ChIP assays, input DNA and immunoprecipitated DNA were
amplified by SYBR Green-based real-time PCR. Primers were designed
to interrogate four positions in the Gad1 locus, with the following chro-
mosome 2 (mm9) coordinates: (1) 70330778–70330906, 77 kb up-
stream of the Gad1 TSS; (2) 70352784–70352899,55 kb to Gad1-TSS;
(3) 70399957–70400075 atGad1-TSS; and (4) 70437331–70437444,37
kb downstream from Gad1-TSS.
RNA-seq. RNA was extracted from 	75–100 mg of gray matter of 6
adult control PFC specimens with Rneasy Lipid Tissue mini kit (catalog
#74804, QIAGEN), treated with DNase I, purified, and diluted to 20
ng/l. Sequencing libraries were prepared according to the NuGen Ova-
tion RNASeq version 2 protocol, and run on the paired-end 50 bp mod-
ule in Illumina HiSeq 2000 (Eurofins MWG; Operon). RNA-seq raw
reads that passed the QCmetric, which is called as the “chastity filter” by
Illumina, were aligned to the UCSC Homo sapiens reference genome
build 19 using TopHat version 1.4.0 default parameters, allowing a max-
imum of 2 mismatches when mapping reads to the reference and multi-
ple alignments per read (up to 40 by default). Raw reads that passed
Illumina’s chastity filter varied from 22,470,801 to 60,734,424. TopHat
uses the bowtie version 0.12.8 algorithm to perform the alignment in first
phase and then identifies potential splice junctions by using these map-
ping results and aligns previously unmapped reads in second phase to
generate alignment files. The resulting aligned bam files were processed
by SAMtools (Li et al., 2009), and the read coverage of indexed alignment
files for each sample was visualizedwith the Integrative Genomic Viewer.
For intranuclearRNAseq, FACS-sorted neuronalNeuNnuclei (Jiang et
al., 2008) (
3  106) from adult C57BL/6J cerebral cortex were sub-
jected to total RNA isolation using trizol (Invitrogen) reagent. Ribso-
somal and other RNAs 200 nt were removed using RNA clean and
Concentrator kit (ZymoResearch) followed byDNAdigestion. A total of
20 ng/l (10 l total 200 ng) RNA was fragmented at 95°C for 5 min
using Invitrogen fragmentation buffer (from SuperScript III). First-
strand synthesis was performed using Random primer (Invitrogen; cat-
alog #48190011) and Superscript III. First-strand cDNA was cleaned
usingAmpureXPbeads followedby second-strand synthesis using dUTP
mixture (dUTP 20 mM, dATP, dCTP, dGTP 10 mM) and DNA polymer-
ase I (10U/l, NEB). Double-stranded cDNA was end-repaired using
Klenow DNA polymerase END-repair kit (Epicenter) followed by
A-tailing and adapter ligation. Ampure XP beads were again used to
purify the adapter ligated double-stranded DNA followed by Uracil-
DNAGlycosylase (NEB, M0280S) incubation to remove dUTP contain-
ing second strand. Strand-specific single-stranded DNA was again
purified using Ampure XP beads followed by PCR using adapter specific
barcoded PCRprimers. Purified library was confirmed using bioanalyzer
high-sensitive DNA ChiP analysis followed by deep-sequencing using
Illumina multiplexing protocol and bioinformatical analyses as de-
scribed above.
Statistical methods. Data comparing two groups were analyzed with
two-tailed t tests, paired or unpaired, where appropriate. Data on GAD1
RNA expression in PFC versus fibroblasts (FIB) was analyzed using the
Wilcoxon signed rank test. Data with more than two groups were ana-
lyzed by one-way ANOVA having either “locus” or for the picrotoxin/
tetrodoxin-based neuronal activity experiments “treatment” as between
group factors, followed by Bonferronis multiple-comparison test. The
3C data frommouse cortex of animals subjected to systemic administra-
tion of saline versus haloperidol or clozapine were analyzed by two-way
ANOVA having “locus” and “treatment” as between group factors, fol-
lowed by Tukeys honest significant difference test.
Results
Tissue-specific chromosomal architectures at GAD1
(chromosome 2q31) locus
Cortical gray matter from the rostral frontal lobe of four adult
postmortem specimens, ranging in (1) age from 58 to 81 years,
(2) postmortem interval 7–11 h, and (3) tissue pH 6.1–7.2 was
used to prepare 3C libraries from DNA ligase-treated HindIII
digests, to map and quantify physical interactions of noncontig-
uous DNA elements by PCR. Together, we explored 200 kb on
chromosome 2 (171,573,000–171,797,000; HG19) surrounding
the GAD1 TSS (Fig. 1A).
Physical interaction frequencies from our PFC 3C assays are
shown in Figure 1B. Because chromatin fibers are flexible, result-
ing in much higher interactions of neighboring restriction frag-
ments within 20–25 kb range in 3C assays (Gheldof et al., 2006;
Miele et al., 2006), we primarily interrogated physical interac-
tions of GAD1 TSS with DNA sequences that on the linear ge-
nome are positioned 
25 kB from the TSS. With the anchor
primer on the 11.6 kb HindIII fragment harboring GAD1 TSS
(Fig. 1B, green box), the 3C assays from the PFC consistently
revealed in 4 of 4 specimens a robust interaction with a restric-
tion fragment positioned50 kb upstream of the TSS (red box
in Fig. 1B). This interaction was highly significant in the PFC
(F(9,30) 3021, p 0.001 with Bonferroni’s post hoc for multiple
comparisons) and tissue specific because no evidence for this
chromosomal looping was found in 3C assays from cultured fi-
broblasts from two unrelated donors (Fig. 1B). In contrast to
these brain/fibroblast differences inGAD1higher-order chroma-
tin, the physical interaction of noncontiguous DNA elements
across a 75 kb intergenic portion on chromosome 16were similar
between PFC and fibroblasts (mean  SEM: PFC, 0.30  0.02;
fibroblasts 0.32  0.01). Importantly, no PCR product was ob-
served in PFC 3C assays from the same samples when processed
without the critical DNA ligase step (which conjugates noncon-
tiguous DNA elements) before phenol extraction and DNA pu-
rification (Fig. 1B). These findings, together, strongly suggest that
chromosome 2q31 in human PFC, but not fibroblasts, includes a
loop formation (referred to as GAD1-TSS-50kbLoop hereafter) be-
tween the GAD1 TSS with intergenic sequences positioned 	50
kb further upstream.
We noticed that both the GAD1 TSS and its looping partner
sequences positioned 50 kb upstream of GAD1 were epigeneti-
cally decorated with sharp peaks for histone H3 trimethylated at
lysine 4 (H3K4me3) in neuronal chromatin extracted from pre-
frontal cortex (Cheung et al., 2010) (Fig. 1A). The H3K4me3
modification is an epigenetic mark sharply regulated around
TSSs and other regulatory sequences associated with open chro-
matin and active gene expression (Guenther et al., 2005, 2007). In
human cerebral cortex, the H3K4me3 mark shows a preference
for CpG enriched sequences, specifically those not tagged by
DNA cytosine methylation and repressive histone marks (Mau-
nakea et al., 2010). TheH3K4me3 peak at theGAD1TSS (Fig. 1A)
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extended across 2.5 kb (HG19, chromo-
some 2: 171,672,200–171,674,500) and
included all alternative gene proximal
promoters previously associated with
GAD1 expression (Chen et al., 2011). Fur-
thermore, the50 kb upstream sequence
was defined by sharp peaks of histone H3
acetylated at lysine 27 (H3K27ac) in con-
junction with a corresponding spike of hi-
stone H3 monomethylated at lysine 4
(H3K4me1) in ENCODE ChIP-seq tracks
for H1 human embryonic stem cells
(H1ESC), and the human umbilical vein
endothelial and K562 erythroblastoid cell
lines (Dunham et al., 2012) (Fig. 1A). In-
triguingly, in tissue homogenates from
frontal cortex and hippocampus and in
cultured neurons, the 50 kb upstream
fragment interacting with GAD1 TSS
showed similar types of enrichment for
H3K4me1 and H3K27 (Fig. 2A, browser
tracks were loaded with data from Zhu et
al., 2013). Of note, such sharp peaks of
H3K27ac in conjunction with H3K4me1
and H3K4me3 often define DNA ele-
ments that function as enhancers and reg-
ulate gene expression at sites of promoters
positioned further upstream or down-
stream (Barski et al., 2007; Maston et al.,
2012). Therefore, we hypothesized that
GAD1-TSS-50kbLoop is associated with the
open chromatin fraction from the PFC,
specifically with the H3K4me3-tagged
GAD1 TSS interacting with nucleosomes
positioned 50 kb further upstream that
are epigenetically decoratedwith the same
mark. In support of this hypothesis,
GAD1-TSS-50kbLoop was readily detectable
in PFC, a tissuewith robust levels ofGAD1
gene expression, in contrast to fibroblasts,
which lack both the loop and detectable
levels of GAD1 gene transcript (Fig.
1B,C). To test this hypothesis directly, we used3C-ChIP Loop
(Simonis et al., 2007), which is a modified version of the 3C
approach to study chromosomal loopings in selected chroma-
tin fractions enriched by immunoprecipitation. To this end,
we immunoprecipitated HindIII digested chromatin from hu-
man PFC with anti-H3K4me3 antibody followed by PCR to
interrogate ligation products representing GAD1-TSS-50kbLoop
(Fig. 1D). Indeed, pulldown with anti-H3K4me3 antibody re-
sulted in much stronger enrichment for GAD1-TSS-50kbLoop
compared with pulldown with IgG control; furthermore, no
PCR products from noncontiguous DNA sequences were ob-
served in 3C-ChIP Loop experiments without ligase (Fig. 1D).
We conclude that GAD1-TSS-50kbLoop is a higher-order chro-
matin structure in which at least one or both sides of the loop
are enriched with the H3K4me3 mark.
DNA elements in GAD1-TSS -50kbLoop facilitate transcription
As discussed above, the loop formation in chromosome 2q31,
resulting in a physical interaction between the sequences sur-
rounding the GAD1 TSS with DNA positioned 50 kb further
upstream, is associated with GAD1 gene expression and open
chromatin-associated histonemethylation and acetylation in hu-
man PFC. Of note, the interacting DNA upstream of GAD1 is
associated with sharp histone modification peaks associated with
enhancer functions, including H3K27ac and H3K4me1 in pe-
ripheral cell lines and H3K4me3 in PFC neurons, but in the ab-
sence of detectable (above background) cis-associated transcript
at the peak site (Fig. 1A, red box; Fig. 2A) in our deeply sequenced
total RNA extracts from PFC of six control subjects (Fig. 2B).
These findings, together, would suggest that the upstream com-
ponents of GAD1-TSS-50kbLoop function most likely as enhancers
by facilitating transcription when brought in proximal position
to a gene promoter. To explore this, we focused on 115 bp (chro-
mosome 2: 171622200–171622315, HG19) which, based on
TFSearch (http://www.cbrc.jp/research/db/TFSEARCH.html)
(Heinemeyer et al., 1998), was highly enriched for a total of seven
activating proteinAP-1 early response transcription factormotifs
(TGAG/CTCA), reflecting a much higher AP-1 motif density, or
60 AP-1 sites/kb, comparedwith the surrounding 15 kbwith only
1.2 AP-1 sites/kb. The AP-1 motif is thought to mediate a signif-
icant portion of activity-dependent gene expression both in hu-
man and rodent PFC (Covington et al., 2010). We fused this 115
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Figure 2. Epigenetic and transcriptional landscapes at the GAD1 (chromosome 2q31) locus. A, Browser tracks (ChIP-seq)
showing (top to bottom) H3K4me1 landscape at GAD1 locus (2q31) in cultured neurons (N), and H3 acetylated at lysine 27
(H3K27ac) in hippocampal (Hi) and PFC and cingulate gyrus (CG) postmortem tissue, based on datasets from Zhu et al. (2013).
There is a sharp histone acetylation and methylation peak at interacting DNA sequences (red and green boxes) of chromosomal
loop,GAD1-TSS-50kbLoopdescribed in Figure 1.B, Browser tracks (RNAseq) from total RNAextracts fromPFCof six adult controls (see
Materials and Methods). In this portion of 2q31, RNA tags exclusively arise from GAD1 gene, whereas upstream sequences lack
signal above background.
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bp sequence 5 from aminimal promoter sequence and explored
changes in transcriptional activity with a luciferase assay inHEK-
293 cells. Indeed, in 3 of 3 experiments, addition of the 100 bp
element resulted in a robust, 
10-fold increase in luciferase ex-
pression and activity, compared with a control sequence void of
AP-1 motifs (Fig. 3). These findings support the hypothesis that
GAD1-TSS-50kbLoop plays a role in the regulation of GAD1 tran-
scription, by positioning upstream enhancer sequences in close
proximity to GAD1 TSS.
Higher-order chromatin in chromosome 2q31
(GAD1-TSS -50kbLoop) emerges during the course of neural
differentiation
The above experiments suggest that physical interactions of open
chromatin-associated DNA elements at the GAD1 locus, includ-
ing GAD1-TSS-50kbLoop, are tissue specific and readily detectable
in PFC. Of note, PFC is defined by robust expression of GAD1
RNA, in contrast to skin fibroblasts, which lack both detectable
levels of gene expression and a tractable 3D chromosomal architec-
ture at this locus (Fig. 1B,C). To further test the association between
GAD1-TSS-50kbLoop and active gene expression, we studied GAD1
higher-order chromatin and gene expression both in induced pluri-
potent stem cells (which were generated from one of the two fibro-
blast cultures used for 3C assays shown in Fig. 1B,C) and during
their transition into differentiated neural cultures primarily com-
prised of microtubule-associated protein 2-immunoreactive neu-
rons (Fig. 4A,B). Indeed, GAD1-TSS-50kbLoop, but no other DNA
elements across a 220 kb segment of chro-
mosome 2q31, showed a differentiation-
induced, significant increase in interaction
with theGAD1TSS (Fig. 4B,C), in conjunc-
tion with increased GAD1 RNA expression
(Fig. 4D). Levels of GAD1-TSS-50kbLoop in
the pluripotent stemcellswere	50% lower
comparedwith the neural cultures differen-
tiated from them (Fig. 4D), whichwould be
consistent with the notion that pluripotent
cells maintain some degree of open chro-
matin, including histone acetylation
and H3K4-trimethylation, at genes poised
for expression during subsequent devel-
opment and differentiation (Vastenhouw
and Schier, 2012). The observed increase in
GAD1-TSS-50kbLoop structures upon neural
differentiation was highly specific for this
type of higher-order chromatin because no
loop structures were observed in 3C assays
from cell cultures without the ligation step
(Fig. 4C). Furthermore, the physical inter-
actions of noncontiguous DNA elements
across a 75 kb intergenic portion on chro-
mosome 16, which is insensitive to cellular
differentiation (Ferraiuolo et al., 2010),
were very similar between stemcells (0.31
0.01) and differentiated neural cultures
(0.33 0.01).
GAD1 higher-order chromatin is
conserved in rodent and
primate species
Wenoticed that, inmouse cerebral cortex,
histone H3K4me3 landscapes around the
chromosome 2qC2 Gad1 locus (Fig. 5A)
show a striking resemblance to the epigenetic profile encountered
in neuronal chromatin from human (Fig. 1A). Both mouse and
primate cortex exhibits sharp H3K4me3 peak profiles both at the
GAD1/Gad1 TSS and a conserved CpG-rich sequence positioned
55 kb (50 kb) upstream ofGad1 (GAD1) gene. The CpG-rich
sequences at50 kb from theGAD1TSS (HG19, chromosome 2:
171,627,226–171,628,062) include a 302 bp sequence that shows
88% sequence homology to mouse (mm9, chromosome 2:
70,347,243–70,347,545). This degree of conservation is much
higher than what is expected, given that the 10 kb of surrounding
sequence shows a much lower degree, or 47.2%, of sequence
conservation (mm9 chromosome 2: 70342243–70352545 to hg19
chromosome 2: 171621775–171629528). Furthermore, as for hu-
man PFC (tissue homogenate) (Fig. 2B), RNAseq from neuronal
nuclei of mouse cerebral cortex did not reveal evidence for cis-
associated transcript at the H3K4me3 peak site positioned 55
kb upstream of Gad1 (mouse chromosome 2qC2) (Fig. 5A, red
box). Furthermore, inspection of the H3K4me3 ChIp-seq data-
sets from PFC neurons and nonhuman primate prefrontal cor-
tex, including macaque and chimpanzee (Shulha et al., 2012b),
revealed epigenetic profiles at theGad1 locus very similar to those
observed in human and mouse, with H3K4me3 peaks limited to
the Gad1 TSS and the conserved CpG-rich sequence positioned
	50 kb further upstream: Rhesus macaque genome RM3, chro-
mosome 12: 34110698–34112216 and chimpanzee (Pan troglo-
dytes) genome PT3 chromosome 2B: 175198622–175200113.
Given the conserved H3K4me3 landscapes between mouse and
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primate brains, we hypothesized that 3D genome architectures in
mouse cerebral cortex will include a homolog to the aforemen-
tioned GAD1-TSS-50kbLoop from the human PFC, with a con-
served enhancer sequence positioned 55 kb upstream of Gad1
directly interacting with the Gad1 promoter. Indeed, 3C assays
frommouse cerebral cortex consistently revealed highest levels of
interaction between the Gad1 TSS and the HindIII restriction
fragment harboring the H3K4me3-decorated, CpG-rich se-
quence positioned 	55 kb further upstream (Fig. 5A). We con-
clude that GAD1-TSS-50kbLoop is not unique to (human)
chromosome 2q31 because very similar chromatin architectures,
including Gad1-TSS-55kbLoop, are observed in mouse brain.
Gad1-TSS -55kbLoop is specific for GABAergic neuron
chromatin and regulated by neuronal activity
Of note,GAD1-TSS-50kbLoop in human is lacking in fibroblasts but
highly regulated in brain where it is tightly linked to open chro-
matin and active expression of the GAD1 gene (Fig. 1B–D) and
upregulated during the course of neuronal differentiation (Fig.
4). Therefore, we hypothesized that this chromosomal loop is a
defining feature of GABAergic neurons, which in brain are the
only cell type expressing high levels ofGAD1/GAD67GABA syn-
thesis enzyme (and of a closely related gene, GAD2/GAD65). To
address this question, we first generated BAC transgenic mice
expressing GFP-conjugated histone H2B under control of the
Gad2 gene promoter. We confirmed widespread expression of
the transgene in cortical, hippocampal, and striatal GABAergic
neurons (Fig. 5B) and then conducted 3C assays separately for
GFP and GFP nuclei collected by fluorescence-activated nu-
clei sorting from cerebral cortex and hippocampus of adult
Gad2-H2BGFP mice. Strikingly, Gad1-TSS-55kbLoop was highly
specific for the population of GABAergic (GFP) nuclei and
completely absent in chromatin of non-GABAergic cells (Fig.
5C). This effect was consistently observed in 3 of 3 experiments.
Therefore, Gad1-TSS-55kbLoop, a higher-order chromatin struc-
ture associated with Gad1 gene expression, is part of the genome
architecture specific for GABAergic neurons.
Activity-dependent regulation of Gad1/Gad67 gene expres-
sion is important for the orderly balance of inhibition and exci-
tation in the cerebral cortex both in rodent and primates. For
example, in monkeys, monocular deprivation of sensory input
into visual cortex results after 5 d in a strong and prolonged
downregulation of Gad1/Gad67 RNA in the ocular dominance
columns innervated by the affected eye (Benson et al., 1994). In
the rat, loss of hippocampal pyramidal neurons and hippocam-
pal–prefrontal connectivity results in downregulated Gad1/
Gad67 expression in hippocampus (Shetty and Turner, 2001)
and prefrontal cortex (Lipska et al., 2003). Decreased Gad1/
Gad67 expression, in turn, results in reduced levels of cytosolic
GABA levels and lower amplitudes of miniature inhibitory syn-
aptic postsynaptic currents (mIPSCs) (Lau and Murthy, 2012).
Given that activity-regulated fine-tuning of Gad1/Gad67 expres-
sion is of pivotal importance for homeostatic plasticity both in
primate and rodent cerebral cortex, we asked whether higher-
order chromatin structures around the GAD1 locus, including
GAD1-TSS-50kbLoop and its mouse homolog, Gad1-TSS-55kbLoop
are involved in these mechanisms. We explored this question in
primary cultures frommouse hippocampus, which were exposed
for 15 h either to vehicle (DMSO) or the GABAA receptor antag-
onist picrotoxin (PTX) (100 M) to increase general neuronal
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Gad1.Data fromprimaryneuronal culture frommousehippocampus, (left)Gad1RNAand (right) 3Cassays, showing chromosomal looping connectingTSSwith55kbupstreamDNA elements (B, C) after
15 h of PTX or TTX treatment. N 3 experiments/group, meanSEM,expressed relative to control (DMSO-treatedcultures).Gad1RNAwasconsistently (3of3experiments)upregulated inPTX-treated
cultures and decreased after TTX,whereasGad1 3C interactionswere consistently increased in 3 of 3 experiments after PTX-induced increase in neuronal activity (one-way ANOVA, RNA: F(2,12) 26.74 (p
0.001), one sample t test, DMSO versus PTX (p 0.05), DMSO versus TTX (p 0.01), 3C F(2,6) 126.6 (p 0.001), post hocBonferroni DMSO versus PTX (p 0.001). E, CBP occupancy in chromatin from
mousecerebralcortex,expressedaschip-to-inputratio,atmultiplepositionsattheGad1 locus,as indicated.CBPlevelsaresignificantly increasedat55kbandtheinteractingsequencesatGad1-TSS,compared
with77 kbupstreamand37 kbdownstream fromTSS (N 3 adultmice,mean SD). One-wayANOVA: F(3,8) 88.76 (p 0.001). Bonferroni-corrected: *p 0.01; **p 0.001).
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activity, or the sodium channel blocker TTX (1M) for silencing.
As expected, Gad1/Gad67 RNA levels were consistently increased
(3 of 3 experiments) by 70% in PTX-treated cultures but decrease
by 	40% after TTX, compared with vehicle controls (Fig. 5D).
This was associated with a consistent (3 of 3 experiments) 50%
increase in physical interactions of theGad1TSSwith its partner-
ing sequences in Gad1-TSS-55kbLoop after treatment with PTX,
compared with vehicle control (Fig. 5D). In contrast, Gad1-
TSS-55kbLoopwas not affected byTTX treatment.We conclude that
Gad1 higher-order chromatin is dynamically regulated upon
acute changes in neuronal activity, particularly in the context of
increased excitation.
Our results show that DNA elements positioned 50 (human)
or 55 (mouse) kb upstream of GAD1/Gad1 facilitate transcrip-
tion and engage in a loop formation with the gene’s TSS that is
upregulated upon increased neuronal activity and transcription.
Therefore, we hypothesized that both portions of the loop, in-
cluding chromatin at site of the Gad1 TSS and its partnering
sequences positioned 55 kb further upstream, show increased
occupancy for proteins, such as the CREB-binding protein and
histone acetyltransferase, CREBBP/CBP, which, like its close ho-
molog EP300, acts as a broad facilitator of gene expression (Alar-
con et al., 2004; Korzus et al., 2004; Wood et al., 2006; Kim et al.,
2010). To explore this, we conductedChIP assays on adultmouse
cerebral cortex and measured CBP binding in Gad1-TSS-55kbLoop
chromatin and additional positions in chromosome 2qC2. In-
deed, CBP load was significantly higher at the Gad1-TSS and its
partnering sequences 55 kb further upstream, compared with
chromatin positioned77 kb upstream, or37 kb downstream
from the TSS (Fig. 5E).
Decreased GAD1-TSS -50kbLoop in prefrontal cortex of subjects
with schizophrenia
Subjects on the mood and psychosis spectrum, including many
cases diagnosed with schizophrenia or bipolar disorder, are fre-
quently affected by dysregulated gene expression in GABAergic
interneurons in multiple brain regions (Guidotti et al., 2000;
Konradi et al., 2011b). In the PFC (in particular, 30% or 40% of
subjects with schizophrenia) are affected by a robust deficit in
GAD1/GAD67 gene expression (Volk et al., 2012). Consistent
with this observation, open chromatin-associated histone modi-
fications, including trimethylation of H3K4 and acetylation of
other lysine residues, are decreased in nucleosomes surrounding
the GAD1 TSS in the PFC of a subset of cases with schizophrenia
(Huang et al., 2007; Tang et al., 2009). Given that the murine
homolog of GAD1-TSS-50kbLoop is specific for GABAergic neuron
chromatin (Fig. 5C), and given the tight coregulation of this loop
with GAD1/Gad1 expression both in and ex vivo in the human
and the mouse (Figs. 1B–D, 4D, and 5D), we hypothesized that
this type of higher-order chromatin is altered in cases with
schizophrenia that are affected by loss of GAD1 gene expression.
To explore this, we conducted 3C assays on PFC tissue of 10 cases
with schizophrenia and 7 controls, including 5 case-control pairs
(matched for age/gender/autolysis time) previously found to
show decreased GAD1/GAD67 RNA expression and H3K4 trim-
ethylation in the disease case (Huang et al., 2007). Indeed, com-
parison of the general cohort of schizophrenics and controls, and
separate analyses of the 5 case-control pairs revealed a significant
(at least 35–45%) decrease in physical interaction frequencies
between the GAD1-TSS and its partnering sequences positioned
50 kb further upstream (Fig. 6A,B). Consistent with the find-
ings from the aforementioned postmortem studies that loss of
transcription-associated epigenetic decorations of sequences
GAD1TSS are not caused by antipsychoticmedication (Huang et
al., 2007; Tang et al., 2009), no quantitative changes in the
strength ofGad1-TSS-55kbLoopwere observed in cerebral cortex of
mice chronically treated with the conventional antipsychotic and
dopamine D2-like receptor antagonist, or atypical antipsychotic
clozapine (Fig. 5A).
Discussion
Summary of results
Mapping physical interactions of noncontiguous DNA elements
across 200 kb surrounding the GAD1/GAD67 GABA synthesis
enzyme gene locus in human PFC, we discovered a loop forma-
tionGAD1-TSS-50kbLoop. The existence ofGAD1-TSS-50kbLoop, and
Gad1-TSS-55kbLooop, as itsmouse homolog, provides testimony for
actively regulated higher-order chromatin structures in the hu-
man brain because GAD1-TSS-50kbLoop was absent in 3C assays in
which the critical DNA ligase step was omitted; furthermore, the
loop was coregulated with GAD1 gene expression and therefore
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Figure 6. Higher-order GAD1 chromatin is altered in PFC of subjects with schizophrenia.
GAD1-TSS-50kbLoop in PFC, asmeasured by PCR for GAD1 TSSwith50 kb upstream sequences.
Top, Bar graph,Mean3C interaction on y-axis generated fromN10 subjectswith schizophre-
nia (SCZ) compared with N 7 controls. **p 0.001 (two-tailed t test). Bottom, Bar graph
represents 3C interaction difference betweenN 5 SCZ-control pairsmatched for age, gender,
and autolysis time. There are significant differences between schizophrenia and control group:
p 0.05 (two-tailed t test).
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much stronger in cultured neurons compared with their undif-
ferentiated precursors or the donors’ skin fibroblasts. In mature
cerebral cortex, the Gad genes are selectively transcribed in cor-
tical interneurons; and indeed, our 3C assays on sorted nuclei
revealed that Gad1-TSS-55kbLoop was specific for GABAergic neu-
rons. These findings, together, suggest that GAD1-TSS-50kbLoop
serves as a classical promoter/enhancer loop (Ong and Corces,
2011), by moving conserved DNA elements positioned 50 kb
upstream of GAD1 into close proximity with the gene’s TSS to
facilitate its expression. In support of this model, the upstream
interacting sequences are decorated with sharp peaks of histone
H3 acetylated at lysine 27 (H3K27ac) in conjunction withmono-
methyl and trimethyl H3K4 (H3K4me1/3), which is of interest
because co-occurrence of these histone modifications often de-
fines enhancer elements (Barski et al., 2007; Zhou et al., 2011;
Maston et al., 2012). In addition, we observed increased occu-
pancy of the transcriptional facilitator, CBP/CREBBP, a protein
that on a genome-wide scale preferentially locates both to gene
proximal promoters and enhancers (Visel et al., 2009; Kim et al.,
2010), at the two interacting sequences inGad1-TSS-55kbLoop. Fur-
thermore, we deeply sequenced in the present study total RNA
from tissue homogenates of human PFC, and frommouse cortex
neuronal nuclei, and observed that none of the upstream DNA
elements in GAD1-TSS-50kbLoop and Gad1-TSS-55kbLoop was tran-
scribed in the cortex. Instead, these sequences harbored AP-1
transcription factor motifs; and, as expected for an enhancer se-
quence, when fused to generic promoters, we observed increased
expression of the luciferase reporter.
Implications for the neurobiology of schizophrenia
Chromosomal loopings, including the GAD1-TSS-50kbLoop de-
scribed here, are among the most highly regulated supranucleo-
somal structures and pivotal for transcriptional regulation, by
enabling distal regulatory enhancer or silencer elements posi-
tioned a few or many hundred kilobases apart from a gene, to
interact directly with that specific promoter (Gaszner and Felsen-
feld, 2006; Wood et al., 2010). Surprisingly, however, only very
few studies explored loop formations in brain tissue (Horike et
al., 2005; Dhar et al., 2009; Jiang et al., 2010; Yasui et al., 2011;
Shen et al., 2012; Shulha et al., 2012b). Our study is the first to
(1) monitor the emergence of higher-order chromatin at a
GABAergic gene locus during the process of neural differentia-
tion, and demonstrate that epigenetic architectures, including a
specific promoter/enhancer loop, are (2) conserved between ro-
dent and primate (including human) Gad1/GAD1, (3) sensitive
to changes in neuronal activity, and (4) significantly dysregulated
in PFC of subjects with schizophrenia affected by loss of GAD1
gene expression. It remains to be determined whether the weak-
ening of prefrontalGAD1-TSS-50kbLoop in a specific disease case is
the result of genetic factors (including the GAD1 risk haplotypes
in selected populations) (Addington et al., 2005; Lundorf et al.,
2005; Straub et al., 2007; Ayalew et al., 2012) or the outcome of a
developmental defect (Benes, 2012) or altered glutamate NMDA
receptor signaling (Behrens et al., 2007; Homayoun and
Moghaddam, 2007; Lisman et al., 2008; Belforte et al., 2010) or
simply an adaptive response to cortical dysfunction, or combina-
tion thereof. In either case, a prolonged decrease ofGAD1 is likely
to be detrimental for higher cognitive function and the inhibitory
networks in the cortex, given that Gad1 is important for homeo-
static synaptic scaling by controlling GABA release and mIPSCs
(Lau and Murthy, 2012), and the orderly formation of periso-
matic innervation of cortical pyramidal neurons and basket neu-
ron innervation fields in the adolescent cortex (Chattopadhyaya
et al., 2007). Furthermore, GAD1 shares genetic risk factors that
lead to alterations in the expression of the cation chloride
cotransporters NKCC1/KCC2, which are of pivotal importance
for the fine-tuning the inhibitory/excitatory effects of postsynap-
tic GABAA receptor-mediated currents (Hyde et al., 2011).
Outlook
In the present study, we first mapped physical interactions be-
tween noncontiguous DNA elements in postmortem brain spec-
imens collected several hours after death, then explored these
types of higher-order chromatin in cell culture and animal mod-
els. The implications of our study, when viewed as a proof of
principle, are obvious: Only 1% of the human genome encodes
protein. However, the vast majority of noncoding sequences are
engaged in various open and repressive higher-order chromatin
structures involved in genome organization and function
(Lieberman-Aiden et al., 2009), but in the human brain these
mechanisms until now remain completely unexplored. Because
both the intergenic portions of the genome and its intronic se-
quences each harbor at least 40% of DNA polymorphisms and
structural variants associated with complex traits and common
medical (including psychiatric) conditions (Stranger et al., 2011),
the findings presented here will pave the way for a more compre-
hensive mapping of 3D genome architectures in normal and dis-
eased human brain. Such type of information, in conjunction
with genome-wide DNA methylation and histone modification
mappings (Mill et al., 2008; Kano et al., 2012; Labonte et al., 2012;
Numata et al., 2012; Shulha et al., 2012a; Guintivano et al., 2013),
will provide deep insights into the coordinated regulation of the
epigenetic landscape of neuronal and glial genomes, including
the role of DNA sequence variants, in specific disease cases diag-
nosed with schizophrenia and other psychiatric disease. Finally,
the observation that the GAD1-associated chromosomal loop
and the H3K4 trimethylation landscape associated with it are
conserved between rodent and primate brain would suggest that
higher-order chromatin, just as recently reported forDNAmeth-
ylation, histone regulation, and transcription factor occupancies,
shows robust homologies between species from different mam-
malian lineages (Xiao et al., 2012). Thus, the “genome in 3D” is
fully open to study in human brain and preclinical models alike.
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